相似文献
1
Analysis of prosthetic cardiac devices: a guide for the practising pathologist.
J Clin Pathol. 2005 Feb;58(2):113-24. doi: 10.1136/jcp.2004.020271.
2
The failure modes of biological prosthetic heart valves.
J Long Term Eff Med Implants. 2001;11(3-4):115-35.
3
[Progress in prosthetic heart valves].
Nihon Rinsho. 1986 Jul;44(7):1698-707.
4
The influence of design on bioprosthetic valve durability.
J Long Term Eff Med Implants. 2001;11(3-4):137-49.
5
Haemodynamic evaluation of the Hancock bovine pericardial heart valve.
Z Kardiol. 1986;75 Suppl 2:241-4.
6
Are bioprostheses superior to mechanical valves?
Z Kardiol. 1986;75 Suppl 2:286-8.
7
Cardiac valve replacement in children: comparison of tissue with mechanical prostheses.
J Thorac Cardiovasc Surg. 1979 Jul;78(1):123-7.
8
Prosthetic heart valves: types and echocardiographic evaluation.
Int J Cardiol. 2007 Nov 15;122(2):99-110. doi: 10.1016/j.ijcard.2006.12.037. Epub 2007 Apr 16.
9
Bioprostheses are superior to mechanical prostheses.
Z Kardiol. 1986;75 Suppl 2:258-71.
10
Prosthetic heart valves.
Cardiol Clin. 2011 May;29(2):229-36. doi: 10.1016/j.ccl.2011.01.007.
引用本文的文献
1
Material Safety of Styrene-Block-Ethylene/Butylene-Block-Styrene Copolymers Used for Cardiac Valves: 6-Month In Vivo Results from a Juvenile Sheep Model.
Eur J Cardiothorac Surg. 2025 Aug 2;67(8). doi: 10.1093/ejcts/ezaf266.
2
Trends in complications of cardiac and vascular prosthetic devices, implants, and grafts mortality rate in the United States (1999-2020).
Ann Med Surg (Lond). 2025 Jan 9;87(1):234-241. doi: 10.1097/MS9.0000000000002850. eCollection 2025 Jan.
3
Pathology of the Aortic Valve: Aortic Valve Stenosis/Aortic Regurgitation.
Curr Cardiol Rep. 2019 Jul 5;21(8):81. doi: 10.1007/s11886-019-1162-4.
4
Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials.
Biomaterials. 2011 Dec;32(34):8783-96. doi: 10.1016/j.biomaterials.2011.08.010. Epub 2011 Sep 7.
本文引用的文献
1
Pathological considerations in replacement cardiac valves.
Cardiovasc Pathol. 1992 Jan-Mar;1(1):29-52. doi: 10.1016/1054-8807(92)90006-A.
2
Approach to the analysis of cardiac valve prostheses as surgical pathology or autopsy specimens.
Cardiovasc Pathol. 1995 Oct-Dec;4(4):241-55. doi: 10.1016/1054-8807(95)00051-6.
3
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
Circulation. 2004 May 18;109(19):2273-8. doi: 10.1161/01.CIR.0000129767.45513.71. Epub 2004 May 3.
4
Polymer-based paclitaxel-eluting coronary stents. Clinical results in de novo lesions.
Herz. 2004 Mar;29(2):147-51. doi: 10.1007/s00059-004-2555-7.
5
Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.
Ann Pharmacother. 2004 May;38(5):845-52. doi: 10.1345/aph.1D261. Epub 2004 Mar 23.
6
Thrombosis and drug-eluting stents: a critical appraisal.
Rev Cardiovasc Med. 2004 Winter;5(1):9-15.
7
Early experiences and clinical implications of drug-eluting stents: part 1.
Ann Pharmacother. 2004 Apr;38(4):661-9. doi: 10.1345/aph.1D256. Epub 2004 Feb 6.
8
Perspectives of drug-eluting stents: the next revolution.
Am J Cardiovasc Drugs. 2002;2(3):163-72. doi: 10.2165/00129784-200202030-00004.
9
Mechanical heart valve prostheses: identification and evaluation (erratum).
Cardiovasc Pathol. 2003 Nov-Dec;12(6):322-44. doi: 10.1016/s1054-8807(03)00105-4.
10
The choice of stent-graft for endovascular repair of abdominal aortic aneurysm.
J Cardiovasc Surg (Torino). 2003 Aug;44(4):519-25.
Zotero 插件